JP2004530691A5 - - Google Patents

Download PDF

Info

Publication number
JP2004530691A5
JP2004530691A5 JP2002589473A JP2002589473A JP2004530691A5 JP 2004530691 A5 JP2004530691 A5 JP 2004530691A5 JP 2002589473 A JP2002589473 A JP 2002589473A JP 2002589473 A JP2002589473 A JP 2002589473A JP 2004530691 A5 JP2004530691 A5 JP 2004530691A5
Authority
JP
Japan
Prior art keywords
thiocarbonyl
alkyl
group
substituted
carbocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002589473A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004530691A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/015257 external-priority patent/WO2002092588A2/en
Publication of JP2004530691A publication Critical patent/JP2004530691A/ja
Publication of JP2004530691A5 publication Critical patent/JP2004530691A5/ja
Withdrawn legal-status Critical Current

Links

JP2002589473A 2001-05-11 2002-05-10 芳香族スルホンヒドロキサメートおよびプロテアーゼ阻害剤としてのそれらの使用 Withdrawn JP2004530691A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29037501P 2001-05-11 2001-05-11
PCT/US2002/015257 WO2002092588A2 (en) 2001-05-11 2002-05-10 Aromatic sulfone hydroxamates and their use as protease inhibitors

Publications (2)

Publication Number Publication Date
JP2004530691A JP2004530691A (ja) 2004-10-07
JP2004530691A5 true JP2004530691A5 (https=) 2006-01-05

Family

ID=23115707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002589473A Withdrawn JP2004530691A (ja) 2001-05-11 2002-05-10 芳香族スルホンヒドロキサメートおよびプロテアーゼ阻害剤としてのそれらの使用

Country Status (26)

Country Link
US (3) US6689794B2 (https=)
EP (1) EP1385836A2 (https=)
JP (1) JP2004530691A (https=)
KR (1) KR20040018368A (https=)
CN (1) CN1764655A (https=)
AP (1) AP2003002908A0 (https=)
AR (1) AR040928A1 (https=)
BG (1) BG108285A (https=)
BR (1) BR0209525A (https=)
CA (1) CA2446586A1 (https=)
CO (1) CO5540386A2 (https=)
CR (1) CR7146A (https=)
CZ (1) CZ20032913A3 (https=)
EA (1) EA200301116A1 (https=)
EC (1) ECSP034839A (https=)
HR (1) HRP20030901A2 (https=)
HU (1) HUP0304069A2 (https=)
IL (1) IL158454A0 (https=)
IS (1) IS7003A (https=)
MX (1) MXPA03010326A (https=)
NO (1) NO20034995L (https=)
OA (1) OA12602A (https=)
PL (1) PL367487A1 (https=)
WO (1) WO2002092588A2 (https=)
YU (1) YU85403A (https=)
ZA (1) ZA200308525B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1042290A1 (en) * 1997-11-14 2000-10-11 G.D. SEARLE & CO. Aromatic sulfone hydroxamic acid metalloprotease inhibitor
GB9901147D0 (en) * 1999-01-19 1999-03-10 Merck Sharp & Dohme Therapeutic agents
US6683093B2 (en) * 2000-05-12 2004-01-27 Pharmacia Corporation Aromatic sulfone hydroxamic acids and their use as protease inhibitors
US20040024024A1 (en) * 2001-05-11 2004-02-05 Freskos John N. Aromatic sulfone hydroxamates and their use as protease inhibitors
US20050209278A1 (en) * 2002-04-25 2005-09-22 Mcdonald Joseph J Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
MXPA04010555A (es) 2002-04-25 2005-02-17 Pharmacia Corp Acidos piperidinil- y piperazinil-sulfonilmetil hidroxamicos y su uso como inhibidores de proteasa.
MXPA05000171A (es) * 2002-06-25 2005-04-08 Pharmacia Corp Acido arilsulfonilhidroxamico y derivados de amida y su uso como inhibidores de la proteasa.
US8088737B2 (en) 2003-04-04 2012-01-03 Incyte Corporation Compositions, methods and kits relating to Her-2 cleavage
ATE380025T1 (de) 2003-05-07 2007-12-15 Univ Aberdeen Ketone und reduzierte ketone als therapeutische mittel zur behandlung von knochenerkrankungen
JP2007516982A (ja) * 2003-12-15 2007-06-28 日本たばこ産業株式会社 シクロプロパン化合物及びその医薬用途
WO2005061448A1 (en) * 2003-12-24 2005-07-07 Monash University Compositions and methods for treating vascular conditions
WO2005117882A2 (en) * 2004-04-20 2005-12-15 Incyte Corporation Hydroxamic acid derivatives as metalloprotease inhibitors
US7709516B2 (en) * 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
SG177221A1 (en) 2006-12-15 2012-01-30 Abbott Lab Novel oxadiazole compounds
AU2013305759C1 (en) 2012-08-23 2018-01-18 Janssen Biopharma, Inc. Compounds for the treatment of paramoxyvirus viral infections
CN106794175B (zh) 2014-06-12 2020-06-09 西达-赛奈医疗中心 用于治疗癌症的组合物
CN104292180A (zh) * 2014-10-12 2015-01-21 湖南华腾制药有限公司 一种恶二唑衍生物的制备方法
ES3011633T3 (en) * 2017-08-31 2025-04-07 Ahammune Biosciences Private Ltd Thiophene compounds, process for synthesis and use thereof for the treatment of autoimmune disorders
KR102533605B1 (ko) * 2018-01-10 2023-05-17 주식회사 라이조테크 신규한 페닐설포닐 옥사졸 유도체 및 이의 용도
US20240335453A1 (en) * 2021-07-28 2024-10-10 University Of Kwazulu-Natal METALLO-ß-LACTAMASE INHIBITORS
CN117800921B (zh) * 2024-02-28 2024-06-11 南京市鸿舜医药科技有限公司 一种咪唑烷二酮类hdac抑制剂、制备方法及应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595700A (en) 1984-12-21 1986-06-17 G. D. Searle & Co. Thiol based collagenase inhibitors
US4882434A (en) 1986-10-29 1989-11-21 Takeda Chemical Industries, Ltd. Gamma-lactonecarboxylic acid derivatives and their use as antibacterial agents or intermediates
GB8827305D0 (en) 1988-11-23 1988-12-29 British Bio Technology Compounds
JP3122161B2 (ja) 1991-05-16 2001-01-09 武田薬品工業株式会社 γ−ラクトン免疫抑制剤
US5525629A (en) 1992-04-07 1996-06-11 British Bio-Technology Limited Inhibition of cytokine production
US5376664A (en) 1992-07-27 1994-12-27 The Du Pont Merck Pharmaceutical Company Unsymmetrical mono-3-nitro bis-naphthalimides as anticancer agents
US5455258A (en) 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
GB9307956D0 (en) 1993-04-17 1993-06-02 Walls Alan J Hydroxamic acid derivatives
GB9320660D0 (en) 1993-10-07 1993-11-24 British Bio Technology Inhibition of cytokine production
GB9323165D0 (en) 1993-11-10 1994-01-05 Chiros Ltd Compounds
AU2394795A (en) 1994-04-28 1995-11-29 Du Pont Merck Pharmaceutical Company, The Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents
GB9416897D0 (en) 1994-08-20 1994-10-12 British Biotech Pharm Metalloproteinase inhibitors
BR9509237A (pt) 1994-10-05 1997-10-21 Chiroscience Ltd Compostos peptidila e seu uso terapêutico como inibidores de metaloproteases
CA2238306A1 (en) 1995-12-08 1997-06-12 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
DE69624081T2 (de) 1995-12-20 2003-06-12 Agouron Pharmaceuticals, Inc. Matrix-metalloprotease Inhibitoren
JP4358908B2 (ja) 1996-01-02 2009-11-04 アヴェンティス ファーマシューティカルズ インコーポレイテッド 置換(アリール、ヘテロアリール、アリールメチル又はヘテロアリールメチル)ヒドロキサム酸化合物
KR20000022532A (ko) 1996-06-27 2000-04-25 오노 야꾸힝 고교 가부시키가이샤 아릴(설파이드, 설폭시드 및 설폰)유도체 및 이를 활성 성분으로 함유하는 약물
ES2194209T3 (es) 1996-07-22 2003-11-16 Monsanto Co Inhibidores de metaloproteasa de tiol sulfona.
PT973512E (pt) 1997-02-27 2004-07-30 Wyeth Corp N-hidroxi-2-(alquil, aril ou heteroaril sulfanil, sulfinilou sulfonil)-alquil, aril ou heteroarilamidas substituidas na posicao 3 como inibidores de metaloproteinases da matriz
US6300514B1 (en) 1997-06-25 2001-10-09 Ono Pharmaceutical Co., Ltd. Aryl (sulfide, sulfoxide and sulfone) derivatives and drugs containing the same as the active ingredient
US6576664B1 (en) 1997-08-18 2003-06-10 Bristol-Myers Squibb Pharma Company Inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
EP1042290A1 (en) 1997-11-14 2000-10-11 G.D. SEARLE & CO. Aromatic sulfone hydroxamic acid metalloprotease inhibitor
US20010039287A1 (en) * 1997-11-14 2001-11-08 Thomas E Barta Aromatic sulfone hydroxamic acid metalloprotease inhibitor
US6750228B1 (en) 1997-11-14 2004-06-15 Pharmacia Corporation Aromatic sulfone hydroxamic acid metalloprotease inhibitor
IL127496A0 (en) 1997-12-19 1999-10-28 Pfizer Prod Inc The use of MMP inhibitors for the treatment of ocular angiogenesis
ID25639A (id) 1998-02-19 2000-10-19 American Cyanamid Co Alkil, aril atau heteroarilamida tersubstitusi n-hidroksi-2-(alkil, aril, atau heteroaril sulfanil, sulfinil atau sulfonil)-3 sebagai inhibitor matriks mataloproteinase
AP2001002240A0 (en) 1999-02-08 2001-09-30 Searle & Co Sufamato hydroxamic acid metalloprotease inhibitor.
EP1165500A1 (en) 1999-04-02 2002-01-02 Du Pont Pharmaceuticals Company Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
EP1081137A1 (en) 1999-08-12 2001-03-07 Pfizer Products Inc. Selective inhibitors of aggrecanase in osteoarthritis treatment
US6683093B2 (en) 2000-05-12 2004-01-27 Pharmacia Corporation Aromatic sulfone hydroxamic acids and their use as protease inhibitors

Similar Documents

Publication Publication Date Title
JP2004530691A5 (https=)
JP2008526724A5 (https=)
CA2536870A1 (en) Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
JP2010504286A5 (https=)
JP2008516968A5 (https=)
JP2010535722A5 (https=)
JP2008513504A5 (https=)
RU2005136368A (ru) Производные пиперазина и их применение для лечения неврологических и психиатрических заболеваний
JP2013509392A5 (https=)
JP2008513516A5 (https=)
WO2005105732A8 (en) Substituted methyl aryl or heteroaryl amide compounds
JP2006522035A5 (https=)
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
MX2009008509A (es) Compuesto de anillo puenteado-aza.
EP1325921A3 (en) Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
HRP20050432A2 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
JPWO2019155399A5 (https=)
WO2003066629A3 (en) Heteroaryl compounds useful as inhibitors of gsk-3
CA2371583A1 (en) Piperazine derivatives useful as ccr5 antagonists
AR040803A1 (es) Ligandos de receptores canabinoides, composiciones farmaceuticas, un proceso para su elaboracion y el uso de dichos compuestos, solos o combinados, para la preparacion de medicamentos
JP2012530765A5 (https=)
RU99112569A (ru) Бициклические арильные карбоксамиды и их терапевтическое применение
JP2016500653A5 (https=)
JP2005536531A5 (https=)
JP2007519618A5 (https=)